Skip to main content

Table 2 The absolute change of sequential organ failure assessment score from the baseline

From: Dexmedetomidine improved renal function in patients with severe sepsis: an exploratory analysis of a randomized controlled trial

Data field

DEX group (n = 54)

Non-DEX group (n = 50)

P value

Day 2, n (%)

52 (96)

48 (96)

 

Respiratory subscore, median (IQR)

0 (−1, 0)

0(−1, 1)

0.32

Cardiovascular subscore, median (IQR)

0 (0, 0)

0 (0, 0)

0.38

Neurological subscore, median (IQR)

0 (0, 1)

0 (0, 1)

0.87

Renal subscore, median (IQR)

0 (−1, 0)

0 (0, 0)

0.08

Hepatic subscore, median (IQR)

0 (0, 1)

0 (0, 0)

0.87

Coagulation subscore, median (IQR)

1 (0, 1)

0 (0, 1)

0.32

Total SOFA score, median (IQR)a

1 (−1, 2)

1 (0, 3)

0.20

Day 4, n (%)

43 (80)

41 (82)

 

Respiratory subscore, median (IQR)

0 (−1, 0)

0 (−1, 1)

0.11

Cardiovascular subscore, median (IQR)

0 (−2, 0)

0 (−2, 0)

0.55

Neurological subscore, median (IQR)

0 (−1, 0)

0 (0, 0)

0.22

Renal subscore, median (IQR)

−1 (−1, 0)

0 (−1, 0)

0.02

Hepatic subscore, median (IQR)

0 (0, 1)

0 (0, 1)

0.97

Coagulation subscore, median (IQR)

1 (0, 2)

1 (0, 2)

0.89

Total score, median (IQR)

− 1 (−3, 2)

0 (−3, 3)

0.19

Day 6, n (%)

33 (61)

32 (64)

 

Respiratory subscore, median (IQR)

0 (−2, 1)

0 (−1, 0)

0.93

Cardiovascular subscore, median (IQR)

− 1 (− 3, 0)

0 (−3, 0)

0.52

Neurological subscore, median (IQR)

0 (− 1, 0)

0 (0, 0)

0.37

Renal subscore, median (IQR)

− 1 (−1, 0)

− 1 (−1, 0)

0.23

Hepatic subscore, median (IQR)

0 (0, 1)

0 (0, 1)

0.91

Coagulation subscore, median (IQR)

1 (0, 2)

1 (0, 2)

0.78

Total score, median (IQR)

− 2 (−4, 2)

− 2 (−5, 1)

0.78

  1. DEX dexmedetomidine, SOFA sequential organ failure assessment, IQR interquartile range
  2. aThe SOFA score ranges from 0 to 24, with higher scores indicating more severe disease. The SOFA score consists of six organ-subscores ranges from 0 to 4